These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10779261)

  • 1. The Antiretroviral Pregnancy Registry Interim Report.
    Preboth M
    Am Fam Physician; 2000 Apr; 61(7):2265. PubMed ID: 10779261
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry.
    Covington DL; Tilson H; Elder J; Doi P
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):537-45. PubMed ID: 15317035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal preventive medicine: teratogens and the unborn baby.
    Chernoff GF; Jones KL
    Pediatr Ann; 1981 Jun; 10(6):210-7. PubMed ID: 6265855
    [No Abstract]   [Full Text] [Related]  

  • 4. Accutane registry compulsory in US, but not Canada.
    Andresen M
    CMAJ; 2006 Jun; 174(12):1701. PubMed ID: 16754892
    [No Abstract]   [Full Text] [Related]  

  • 5. Methods of evaluating the alleged teratogenicity of environmental agents.
    Brent RL
    Prog Clin Biol Res; 1985; 163C():191-5. PubMed ID: 3991621
    [No Abstract]   [Full Text] [Related]  

  • 6. An innovative approach to determine fetal risk: the FDA Office of Women's Health pregnancy exposure registry web listing.
    Sharma P; Parekh A; Uhl K
    Womens Health Issues; 2008; 18(4):226-8. PubMed ID: 18468921
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
    Kelsey FO
    Prog Clin Biol Res; 1985; 163C():155-9. PubMed ID: 3991617
    [No Abstract]   [Full Text] [Related]  

  • 8. Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry.
    Scheuerle A; Tilson H
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):465-75. PubMed ID: 12426931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential subversion of pregnancy prevention program in the managed care setting.
    Wilkin JK
    Arch Dermatol; 1997 Feb; 133(2):243-4. PubMed ID: 9041846
    [No Abstract]   [Full Text] [Related]  

  • 10. Improper interpretation of data concerning teratogenicity: a case report.
    Staples RE
    Prog Clin Biol Res; 1985; 163C():161-3. PubMed ID: 3921981
    [No Abstract]   [Full Text] [Related]  

  • 11. [Information services on teratogens and agents toxic for the reproduction].
    Garbis-Berkvens JM; Peters PW
    Ned Tijdschr Geneeskd; 1991 Mar; 135(9):384-7. PubMed ID: 2014060
    [No Abstract]   [Full Text] [Related]  

  • 12. Coping with the isotretinoin registry.
    Baldwin HE
    Dermatol Ther; 2006; 19(4):241-50. PubMed ID: 17005000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The thalidomide story and its lessons].
    Dolev E
    Harefuah; 2001 Jul; 140(7):663-7. PubMed ID: 11481978
    [No Abstract]   [Full Text] [Related]  

  • 14. A pox on your practice. iPLEDGE program scars dermatologists.
    Ortolon K
    Tex Med; 2006 May; 102(5):29-31. PubMed ID: 17115578
    [No Abstract]   [Full Text] [Related]  

  • 15. An information service on teratogenic agents in Brazil.
    Clavijo HA; Schüler L; Sanseverino MT; Giugliani R
    World Health Forum; 1992; 13(2-3):196. PubMed ID: 1418336
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical review procedures for the Antiretroviral Pregnancy Registry.
    Scheuerle A; Covington D
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):529-36. PubMed ID: 15317034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposures in pregnancy that are harmful to the fetus i.e. human teratogens.
    Holmes LB
    Pediatr Res; 1999 Feb; 45(2):286-7. PubMed ID: 10022604
    [No Abstract]   [Full Text] [Related]  

  • 18. Looking for the fingerprint of a teratogen.
    Mekdeci B
    Birth Gaz; 1997; 13(4):47-8. PubMed ID: 9348802
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of birth defects associated with nelfinavir exposure during pregnancy.
    Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
    Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Counseling adolescents about environmental teratogens.
    Williams JK
    Pediatr Nurs; 1986; 12(4):292-5, 304. PubMed ID: 3637772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.